Dr. Marcus has been practicing vitreoretinal surgery in the CSRA since 1994.  Dr. Marcus came to Augusta after extensive training at the Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston.   His 6 years of Harvard Medical School training included a research fellowship in ophthalmic pathology/ocular oncology, ophthalmology residency, and surgical fellowship in vitreoretinal surgery.  Dr. Marcus served as Director of the Retina Service at the Medical College of Georgia in Augusta from 1994-2005 where he was a tenured Professor of Ophthalmology, Vice-Chairman and recipient of the Outstanding Young Faculty Award.  Dr. Marcus has been treating patients at the Southeast Retina Center since 1998 and has joined our practice full-time as of June, 2005.

 Dr. Marcus is devoted to the care of patients with diseases of the macula, retina and vitreous including age-related macular degeneration, diabetic retinopathy, and retinal detachment.  He is recognized nationally as leader in vitreoretinal surgery, clinical retinal research, teaching and laboratory investigation.  Dr. Marcus has brought cutting edge clinical therapies to our region as lead investigator in multiple clinical trials.  His dedication to innovative treatments such as Photodynamic Therapy (PDT) with Visudyne and Macugen for age-related macular degeneration, made these now established therapies  available to our patients prior to their approval to the general patient population.  He continues to make newer therapies available for our patients as he and Dr. Singh participate in clinical trials such as Lucentis for wet macular degeneration (Genentech, Inc.),  Squalamine (Genaera, Inc.) for wet macular degeneration, Oral Protein Kinase Inhibitor (Eli Lilly, Inc.) for diabetic retinopathy, and Macugen (EyeTech, Inc.) for diabetic macular edema.  Dr. Marcus also participates as lead investigator in National Eye Institute sponsored clinical research for the Diabetic Retinopathy Clinical Research network for diabetic retinopathy and retinal vein occlusion.  These studies are evaluating newly designed steroid injections, made specifically for eye injections, in the treatment of diabetic retinopathy and retinal vein occlusion.  He is also internationally recognized as a leader in the investigation of radiotherapy for wet macular degeneration and he advises companies investigating radiation devices for this disease.

 Dr. Marcus is a nationally recognized teacher and innovator.  He lectures throughout the country discussing the latest therapies for retinal diseases.  He has presented scientific material at medical meetings on over 100 occasions and has published almost 90 scientific publications.  He has received the American Academy of Ophthalmology’s Achievement Award and is also Editor-In-Chief of the American Academy of Ophthalmology’s Focal Points, a modular updated text book for the practicing ophthalmologist.  Dr. Marcus is Professor of Clinical Ophthalmology at the University  South Carolina School of Medicine in Columbia, S.C where he teaches ophthalmology residents and has a laboratory and National Eye Institute Grant funding studying novel methods to deliver drugs to the retina. 

 Dr. Marcus is available to our patients or new referral consultations every day of the week.  He is committed to excellent surgical and medical patient care and believes in the need for strong patient-doctor communication.  He is certified by the American Board of Ophthalmology. His complete resume (curriculum vitae) is available by clicking here.

Dr. Marcus has lived in Augusta since 1994 with his wife and three children.  He enjoys running, weight aerobics, playing golf, and spending time with family and friends.